Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank 薬物名（臨床試験情報から抽出） KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Acetate 1件: Acetate---41件: 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299 💬
2 Ascorbic acid 4件: Acidum ascorbicum; Ascorbic Acid; Iron; Vitamin C1件: Ascorbic acid 💬--8件: 10, 97, 192, 206, 210, 211, 212, 298 💬
3 Baclofen 2件: Baclofen; Kemstro1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬8件: 2, 10, 13, 18, 65, 70, 149, 206 💬
4 Biotin 4件: BIOTIN; Biotina; D-BIOTIN; Vitamin B71件: Biotin 💬--5件: 2, 8, 10, 13, 20 💬
5 Mexiletine 4件: Mexiletina; Mexiletine; Mexitil; Namuscla1件: Mexiletine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬5件: 1, 2, 10, 113, 114 💬
6 Naltrexone 2件: Naltrexone; Naltrexone Hydrochloride1件: Naltrexone 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬13件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬
7 Sorbitol 3件: D-glucitol; D-SORBITOL; Sorbitol1件: Sorbitol solution 💬--3件: 10, 28, 299 💬
8 Ubidecarenone 3件: Coenzyme Q-10; Coenzyme Q10; CoQ101件: Ubidecarenone 💬--12件: 2, 5, 6, 8, 10, 18, 46, 57, 86, 113, 214, 215 💬
9 Ulipristal 1件: Ulipristal1件: Ulipristal 💬1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 10 💬